Literature DB >> 8392785

Percutaneous biopsy of portal vein thrombus: a new staging technique for hepatocellular carcinoma.

G D Dodd1, B I Carr.   

Abstract

OBJECTIVE: Accurate staging of hepatocellular carcinoma is necessary to determine appropriate treatment. In particular, neoplastic invasion of the portal vein is a contraindication for hepatic resection or transplantation. Unfortunately, imaging cannot always differentiate benign from malignant portal vein thrombi. We therefore undertook a study to determine the efficacy and safety of sonographically guided percutaneous biopsy of portal vein thrombi as a staging technique for patients with hepatocellular carcinoma. SUBJECTS AND METHODS: We performed percutaneous biopsy of portal vein thrombi in 12 men and two women (43-76 years old) who were being considered for hepatic resection or transplantation. All of the patients had hepatic cirrhosis and 13 had histologically proved intrahepatic hepatocellular carcinoma. Biopsies were performed under continuous color Doppler sonographic guidance by using 20-gauge aspiration needles with occlusive stylets. Each needle was positioned with its tip embedded in the thrombus before the stylet was removed. During aspiration, the needle was carefully controlled to keep its tip within the lumen of the portal vein. To evaluate for possible false-positive results, an additional identical needle was passed in and out of only the hepatic parenchyma in five patients.
RESULTS: Adequate specimens were obtained in all 14 patients. Twelve specimens contained malignant hepatocytes, and two contained benign thrombi. One of the benign thrombi in a patient who had a 3-cm hepatocellular carcinoma of the parenchyma was confirmed by examining the resected liver after transplantation. The other patient who had a benign thrombus had no clinical or imaging evidence of hepatocellular carcinoma. No complications associated with biopsy occurred. None of the control needles contained hepatocytes. The patients' discomfort during biopsy was approximately the same as the discomfort experienced during previous liver biopsies. The average length of the procedure was 20 min.
CONCLUSION: Sonographically guided percutaneous biopsy of portal vein thrombi is a safe, accurate, useful, and well-tolerated diagnostic procedure for the staging of hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1993        PMID: 8392785     DOI: 10.2214/ajr.161.2.8392785

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Utility and Safety of EUS-guided Portal Vein FNA.

Authors:  Sergey Kantsevoy; Paul J Thuluvath
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

2.  Endoscopic Ultrasound -guided Fine-Needle Aspiration of a Portal Vein Thrombus to Aid in the Diagnosis and Staging of Hepatocellular Carcinoma.

Authors:  Hazar Michael; Christopher Lenza; Mala Gupta; Douglas S Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

3.  Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Luciano Tarantino; Umberto Ferbo; Alessandra Bracigliano; Raffaela Vecchione
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

4.  Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.

Authors:  Courtney B Sherman; Spencer Behr; Jennifer L Dodge; John P Roberts; Francis Y Yao; Neil Mehta
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

5.  Liver transplantation for hepatocellular carcinoma.

Authors:  R Selby; Z Kadry; B Carr; A Tzakis; J R Madariaga; S Iwatsuki
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

6.  APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.

Authors:  Cher Heng Tan; Su-Chong Albert Low; Choon Hua Thng
Journal:  Int J Hepatol       Date:  2011-04-19

7.  Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes.

Authors:  B I Carr; V Guerra; R Donghia; S Yilmaz
Journal:  Ann Med Surg (Lond)       Date:  2021-06-02

8.  Macroscopic Portal Vein Thrombosis in HCC Patients.

Authors:  Hikmet Akkiz; Brian I Carr; Sedef Kuran; Ümit Karaoğullarından; Oguz Üsküdar; Salih Tokmak; Burcu Arslan; Figen Doran; Hüseyin Tugsan Balli; Abdulalh Ülkü; Tolga Atılgan Akçam; Halil İbrahim Bahçeci; Kamil Yalçın Polat; Necati Örmeci; Halis Şimşek; Abdullah Sonsuz; Ali Demir; Engin Altıntaş; Mehmet Demir; Kendal Yalçın; Nazım Ekinci; Ayşegül Harmancı Özakyol; Mehmet Yücesoy; Ahmet Uygun; Vito Guerra; Anıl Delik; Yaman Tokat; Sezai Yilmaz; Ahmet Bektaş; Murat Kılıç
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.